safe entry sub 10 cents, page-66

I too have sold out of underperforming mining stocks to get on board with PAB over the last three trading days, I believe this is still in the process of a massive re-rate especially with the announcement this morning.

A sponsored trial with a pharmaceutical company must only mean they are confident of the potential of their product and hopefully this will be fast-tracked to distribution to allow for treatment of patients with MM to give them the respite they need. The trading action on this has escalated each day and seems now that international attention has commenced.

Can only mean further increases as buyers contimue to jump over the sellers to get their hands on the stock. Still a puny market cap for this $500 million per year treatment industry. As the only effective treatment PAB should get a decent share of this IMHO.

Good luck to all